PDR
MCID: PRL007
MIFTS: 57

Proliferative Diabetic Retinopathy (PDR) malady

Summaries for Proliferative Diabetic Retinopathy

About this section
Sources:
32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Proliferative Diabetic Retinopathy, also known as pigmentary disorder, reticulate, with systemic manifestations, is related to diabetic retinopathy and proliferative vitreoretinopathy. An important gene associated with Proliferative Diabetic Retinopathy is SERPINF1 (serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1), and among its related pathways are Rho Family GTPases and Akt Signaling. The compounds vegf and tyrosine have been mentioned in the context of this disorder. Affiliated tissues include endothelial, eye and monocytes, and related mouse phenotypes are immune system and cardiovascular system.

Aliases & Classifications for Proliferative Diabetic Retinopathy

About this section
Sources:
8Disease Ontology, 10DISEASES, 44Novoseek, 60UMLS, 56SNOMED-CT, 27ICD9CM, 39NCIt
See all sources

Aliases & Descriptions:

proliferative diabetic retinopathy 8 10 44 60
pigmentary disorder, reticulate, with systemic manifestations 60
pdr 8


External Ids:

Disease Ontology8 DOID:13207
ICD9CM27 362.02
SNOMED-CT56 154679002, 59276001
NCIt39 C84457

Related Diseases for Proliferative Diabetic Retinopathy

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Proliferative Diabetic Retinopathy via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 225)
idRelated DiseaseScoreTop Affiliating Genes
1diabetic retinopathy32.3TGFB2, ADM, VTN, SERPINF1, VCAM1, CXCL12
2proliferative vitreoretinopathy31.1TGFB2, ADM, VTN, CTGF, CCL2, HGF
3retinal detachment31.1TGFB2, SERPINF1, VEGFA
4diabetic macular edema31.1SERPINF1, VEGFA
5diabetes mellitus30.9VTN, VCAM1, IGFBP1, SST, ANGPT2, VEGFA
6glaucoma30.8TGFB2, SERPINF1, CTGF, TIMP2
7neovascular glaucoma30.8VEGFA
8macular holes30.7TGFB2, ADM, SERPINF1, PTGDS, MIF, ANGPT2
9diabetic nephropathy30.6ADM, SERPINF1, MIF, CTGF, CCL2, TIMP3
10type 2 diabetes mellitus30.6ADM, VCAM1, CXCL10, IGFBP1, GAD1, CCL2
11proteinuria30.4ADM, VTN, ANGPT2, VEGFA, CTGF, CCL2
12ischemia30.2TGFB2, ADM, VTN, CXCL12, EPHB4, ANGPT2
13retinal disease30.2ADM, SERPINF1, VCAM1, EPHB4, IGFBP1, ANGPT2
14osteoarthritis30.2TGFB2, VCAM1, CXCL12, CXCL10, ANGPT2, CTGF
15leukemia30.2SERPINF1, CXCL12, IGFBP1, ANGPT2
16uveitis30.2TGFB2, SERPINF1, CXCL10, CCL2
17macular retinal edema30.2SERPINF1, CXCL12, VEGFA
18coronary artery disease30.2VTN, VCAM1, IGFBP1, CCL2
19encephalitis30.1VCAM1, CXCL10, CCL2
20malaria29.9MIF
21meningitis29.9CXCL10
22hepatitis29.9CXCL10, HGF, TIMP2
23retinitis11.0
24background diabetic retinopathy10.4
25severe nonproliferative diabetic retinopathy10.4
26vitreous detachment10.4
27diabetic cataract10.4
28cataract10.4
29acromegaly10.3
30type 1 diabetes mellitus10.3
31rubeosis iridis10.3
32retinoschisis10.3
33sleep disorder10.3
34vitreous disease10.3
35paragonimiasis10.2
36amyloidosis10.2
37ischemic retinopathy10.2
38carotid stenosis10.2
39choroiditis10.2
40retinal ischemia10.2
41maturity-onset diabetes of the young10.2
42retinitis pigmentosa10.2
43hemochromatosis10.2
44gestational diabetes10.2
45carotid artery disease10.2
46hypothyroidism10.2
47optic atrophy10.2
48retinal degeneration10.2
49hemochromatosis type 210.2
50autosomal dominant neovascular inflammatory vitreoretinopathy10.2

Graphical network of the top 20 diseases related to Proliferative Diabetic Retinopathy:



Diseases related to proliferative diabetic retinopathy

Clinical Features for Proliferative Diabetic Retinopathy

About this section

Drugs & Therapeutics for Proliferative Diabetic Retinopathy

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Proliferative Diabetic Retinopathy

Drug clinical trials:

Search ClinicalTrials for Proliferative Diabetic Retinopathy

Search NIH Clinical Center for Proliferative Diabetic Retinopathy

Search CenterWatch for Proliferative Diabetic Retinopathy

Genetic Tests for Proliferative Diabetic Retinopathy

About this section

Anatomical Context for Proliferative Diabetic Retinopathy

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Proliferative Diabetic Retinopathy:

32
Endothelial, Eye, Monocytes, Placenta, Retina, Myeloid, T cells, Tongue

Animal Models for Proliferative Diabetic Retinopathy or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Proliferative Diabetic Retinopathy:

36 (show all 16)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538710.9SST, ANGPT2, VEGFA, CCL2, TIMP3, TIMP2
2MP:000538510.9TGFB2, HGF, CCL2, CTGF, ANGPT2, EPHB4
3MP:000538410.8GAD1, CTGF, CCL2, HGF, TIMP3, VEGFA
4MP:001076810.8VEGFA, GAD1, CTGF, CCL2, HGF, TIMP3
5MP:000537610.8TIMP3, CCL2, CTGF, GAD1, CXCL10, VCAM1
6MP:000539710.8TIMP2, TIMP3, HGF, CCL2, VEGFA, MIF
7MP:000538110.8CCL2, CTGF, GAD1, VEGFA, ANGPT2, SST
8MP:000287310.7TIMP2, CCL2, CTGF, GAD1, VEGFA, SST
9MP:000537010.7TIMP3, HGF, CCL2, VEGFA, IGFBP1, CXCL12
10MP:000538010.7CTGF, GAD1, EPHB4, VCAM1, ADM, TGFB2
11MP:000301210.6PTGDS, GAD1
12MP:000536910.5EPHB4, CXCL12, TGFB2
13MP:000539110.5TIMP3, ANGPT2, SERPINF1, TGFB2
14MP:000363110.5SERPINF1, GAD1, TIMP2
15MP:000537810.4TIMP3, HGF, CCL2, CTGF, GAD1, VEGFA
16MP:001077110.2TIMP3, CTGF, VEGFA, ANGPT2, PTGDS

Publications for Proliferative Diabetic Retinopathy

About this section
Sources:
50PubMed
See all sources

Articles related to Proliferative Diabetic Retinopathy:

(show top 50)    (show all 574)
idTitleAuthorsYear
1
Optic atrophy after anti-vascular endothelial growth factor injection in diabetic patients with proliferative diabetic retinopathy. (23539935)
2013
2
Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. (23418197)
2013
3
Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy. (23812521)
2013
4
Cytomegalovirus retinitis in a patient with proliferative diabetes retinopathy. (23480605)
2013
5
Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy. (24195074)
2013
6
Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy. (23826525)
2013
7
The role of ILM peeling in vitreous surgery for proliferative diabetic retinopathy complications. (23676224)
2013
8
Proliferative diabetic retinopathy in long-term diabetic patients with and without clinical osteoarthritis. (23154491)
2013
9
Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1I+. (22232563)
2012
10
Relationship between compliance with ophthalmic examinations preoperatively and visual outcome after vitrectomy for proliferative diabetic retinopathy. (22763797)
2012
11
Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. (21937017)
2012
12
Panretinal photocoagulation for proliferative diabetic retinopathy. (22445637)
2012
13
Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. (21757152)
2011
14
The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy. (21724263)
2011
15
Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy. (21851923)
2011
16
Repeated intravitreal bevacizumab (Avastin(Ar)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation. (21272288)
2011
17
Association of homozygous SDF-1 3'A genotype with proliferative diabetic retinopathy. (19381432)
2010
18
Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy? (20057509)
2010
19
Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy. (22553568)
2010
20
Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. (20057344)
2010
21
Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy. (20220056)
2010
22
The results of intravitreal bevacizumab injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy. (20224478)
2010
23
Anti-VEGF therapy in proliferative diabetic retinopathy. (19349790)
2009
24
Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. (19639332)
2009
25
Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase. (19369240)
2009
26
Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. (19151644)
2009
27
Immunohistochemical analysis of cellular adhesion molecules (ICAM-1, VCAM-1) and VEGF in fibrovascular membranes of patients with proliferative diabetic retinopathy: preliminary study. (18834676)
2009
28
Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage. (19672218)
2009
29
Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis. (19516000)
2009
30
The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. (18628999)
2008
31
Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT). (18316393)
2008
32
Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy. (18463519)
2008
33
Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes. (18279437)
2008
34
Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. (18536597)
2008
35
The characteristics of patients presenting with advanced proliferative diabetic retinopathy in Shanxi Eye Hospital, China. (18330448)
2007
36
Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes. (16906278)
2006
37
Role of chemokines in the vitreous of proliferative diabetic retinopathy]. (16218438)
2005
38
The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes. (15638104)
2004
39
Angiogenic activity and VEGF level in sera of diabetic patients with non-proliferative retinopathy]. (15636222)
2004
40
Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot study. (12920663)
2003
41
Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. (11992481)
2002
42
Pars plana filtration with multiple laser perforation of the uvea for neovascular glaucoma following proliferative diabetic retinopathy. (10974296)
2000
43
Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study. (10664320)
1999
44
No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. (10765003)
1999
45
C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. (9869464)
1998
46
Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. (9134347)
1997
47
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. (8703862)
1996
48
Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? (8341493)
1993
49
Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. (7679595)
1993
50
Silicone oil for retinal detachment with advanced proliferative vitreoretinopathy following failed vitrectomy for proliferative diabetic retinopathy. (3946533)
1986

Genetic Variations for Proliferative Diabetic Retinopathy

About this section

Expression for genes affiliated with Proliferative Diabetic Retinopathy

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Proliferative Diabetic Retinopathy

Search GEO for disease gene expression data for Proliferative Diabetic Retinopathy.

Pathways for genes affiliated with Proliferative Diabetic Retinopathy

About this section
Sources:
51QIAGEN, 53Reactome, 29KEGG, 37NCBI BioSystems Database, 12EMD Millipore, 4Cell Signaling Technology
See all sources

Pathways related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.5TIMP2, TIMP3, HGF, CCL2, CTGF, ANGPT2
2
Hide members
10.5TIMP2, TIMP3, HGF, CCL2, CTGF, ANGPT2
3
Hide members
10.5CCL2, VEGFA, SST, CXCL10, CXCL12, VCAM1
4
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, ANGPT2, CXCL10
5
Hide members
10.5TIMP2, TIMP3, HGF, CCL2, CTGF, ANGPT2
610.5TIMP3, HGF, VEGFA, VTN
7
Hide members
10.5HGF, ANGPT2, EPHB4, CXCL10, CXCL12, SERPINF1
8
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, CXCL12, VTN
9
Hide members
10.5CCL2, CXCL10, CXCL12, VCAM1, VTN
10
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, EPHB4, CXCL12
11
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, CXCL12
12
Hide members
10.5TIMP2, TIMP3, HGF, CTGF, EPHB4, CXCL12
13
Hide members
10.5CTGF, HGF, TIMP3
14
Hide members
10.5EPHB4, CTGF, HGF, TIMP3
1510.5VEGFA, TIMP3, TIMP2
16
Cell adhesion ECM remodeling
Hide members
10.5VTN, TIMP3, TIMP2
1710.5TGFB2, ANGPT2, TIMP3, TIMP2
18
Hide members
10.5TIMP2, HGF, CTGF, EPHB4, CXCL12
1910.5VEGFA, IGFBP1, CXCL12, ADM
2010.5CCL2, CXCL10, CXCL12
21
Hide members
10.5VEGFA
2210.5TIMP3
23
Hide members
10.5EPHB4, TIMP3
24
Hide members
10.5IGFBP1, CCL2

Compounds for genes affiliated with Proliferative Diabetic Retinopathy

About this section
Sources:
44Novoseek, 24HMDB, 49PharmGKB, 28IUPHAR, 11DrugBank, 59Tocris Bioscience, 2BitterDB
See all sources

Compounds related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show top 50)    (show all 135)
idCompoundScoreTop Affiliating Genes
1vegf4411.1CTGF, CCL2, HGF, TIMP3, TIMP2, TGFB2
2tyrosine4411.0TIMP2, CXCL10, VTN, MIF, SERPINF1, EPHB4
3retinoic acid44 2412.0MIF, IGFBP1, SST, ANGPT2, CTGF, HGF
4dexamethasone44 49 28 1114.0CXCL12, ANGPT2, VEGFA, CTGF, HGF, TIMP3
5genistein44 28 59 2 11 2416.0SST, VEGFA, CCL2, HGF, TIMP3, TIMP2
6calcium44 49 11 2414.0ANGPT2, GAD1, CTGF, CCL2, HGF, TIMP3
7glucose4411.0TIMP3, CTGF, GAD1, ANGPT2, SERPINF1, TIMP2
8phosphatidylinositol4411.0ADM, CCL2, TIMP3, HGF, CTGF, ANGPT2
9lipid4411.0CCL2, IGFBP1, MIF, CXCL12, CXCL10, ADM
10heparin44 28 11 2414.0CTGF, TIMP3, TIMP2, VEGFA, CXCL12, VCAM1
11ly2940024411.0CCL2, VEGFA, HGF, CTGF, VCAM1, CXCL12
12oxygen44 2412.0ANGPT2, HGF, TIMP2, TIMP3, CCL2, GAD1
13paraffin4411.0ADM, TGFB2, CCL2, VEGFA, ANGPT2, VCAM1
14thymidine44 2412.0TGFB2, TIMP2, HGF, CTGF, ANGPT2, IGFBP1
15cysteine4411.0ADM, VTN, SERPINF1, TGFB2, VCAM1, IGFBP1
16creatinine4411.0IGFBP1, CXCL10, PTGDS, TIMP2, GAD1, ANGPT2
17nitric oxide44 11 2413.0ANGPT2, CTGF, IGFBP1, MIF, CXCL10, VCAM1
18matrigel4411.0TGFB2, CXCL10, CXCL12, VTN
19pge24411.0VTN, SST, VEGFA
20cycloheximide4410.9PTGDS, CXCL12, CXCL10, HGF, IGFBP1
21wortmannin4410.9HGF, CXCL12, TIMP3, CCL2, ANGPT2, CXCL10
22herbimycin a44 5911.9MIF, CXCL12, IGFBP1, CCL2, HGF, VTN
23glycosaminoglycan4410.9TIMP2, TIMP3, CXCL10, CXCL12, TGFB2, VTN
24cholesterol44 28 11 2413.9VCAM1, ADM, VTN, PTGDS, TIMP2, CCL2
25lactate4410.9VCAM1, ADM, VTN, MIF, IGFBP1, SST
26ribonucleic acid4410.9IGFBP1, ANGPT2, TGFB2, CTGF, CCL2, TIMP3
27streptozotocin4410.9ADM, SERPINF1, GAD1, SST
28sb 20358044 5911.9CCL2, CTGF, VEGFA, MIF, CXCL12, TIMP2
29ccl444 2811.9CXCL12, CXCL10, CCL2, HGF
30hyaluronic acid44 2411.9TIMP2, VCAM1, HGF, VEGFA, TGFB2, VTN
31hydrocortisone44 2 59 1113.9ADM, IGFBP1
32arginine4410.9VTN, CCL2, GAD1, SST, VCAM1, HGF
33fibrinogen4410.8IGFBP1, ANGPT2, VCAM1, CTGF, CCL2, TIMP2
34tamoxifen44 49 28 1113.8VTN, CXCL12, IGFBP1, VCAM1
35pioglitazone44 49 28 1113.8CCL2, TIMP2, CTGF, VEGFA, IGFBP1, VCAM1
36prostacyclin4410.8VTN, VCAM1, VEGFA, CTGF, HGF, CCL2
37losartan44 49 28 1113.8TIMP2, ADM, VCAM1, CTGF, CCL2, HGF
38pd 98,0594410.8CXCL12, TIMP3, VCAM1, CTGF, VTN, HGF
39serine4410.8CCL2, CTGF, MIF, SERPINF1, VTN, TIMP2
405fluorouracil4410.7HGF, TIMP2, SST, CXCL12, TGFB2, VEGFA
41testosterone44 59 11 2413.7TIMP3, TGFB2, VCAM1, ADM, PTGDS, IGFBP1
42estradiol44 11 2412.7TIMP3, GAD1, TGFB2
43steroid4410.7IGFBP1, TGFB2, ADM, CXCL12, MIF, TIMP3
44n acetylcysteine4410.7VCAM1, VEGFA, CTGF, HGF, CCL2, SERPINF1
45cytochalasin d44 5911.6CTGF, CXCL12, VCAM1, VTN, CCL2, TIMP2
46tgf beta14410.6CCL2, CTGF, VCAM1, TGFB2, HGF, TIMP3
47cyclophosphamide44 49 1112.5SST, MIF, CXCL12, HGF
48glutamate4410.5GAD1
49norepinephrine44 11 2412.4ADM
50histamine44 28 2412.2CCL2, SST, HGF, PTGDS, VCAM1, ADM

GO Terms for genes affiliated with Proliferative Diabetic Retinopathy

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00557610.7TIMP2, ADM, VTN, SERPINF1, PTGDS, CXCL12
2extracellular spaceGO:00561510.7TIMP2, HGF, TGFB2, ADM, VTN, SERPINF1
3cell surfaceGO:00998610.5TIMP2, VEGFA, MIF, EPHB4, VCAM1
4neuronal cell bodyGO:04302510.5TGFB2, SST, CCL2, TIMP2
5extracellular matrixGO:03101210.4TGFB2, VTN, SERPINF1, TIMP3
6platelet alpha granule lumenGO:03109310.2HGF, VEGFA, TGFB2

Biological processes related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1response to hypoxiaGO:00166610.9TGFB2, ADM, VCAM1, ANGPT2, VEGFA, CCL2
2angiogenesisGO:00152510.8CCL2, CTGF, VEGFA, ANGPT2, EPHB4, TGFB2
3organ regenerationGO:03110010.8HGF, CCL2, ANGPT2, ADM
4negative regulation of angiogenesisGO:01652510.8SERPINF1, CXCL10, ANGPT2, CCL2
5positive regulation of peptidyl-tyrosine phosphorylationGO:05073110.8HGF, VEGFA, MIF, VTN
6positive chemotaxisGO:05091810.8MIF, VEGFA, HGF
7agingGO:00756810.8TIMP2, CCL2, VCAM1, ADM
8response to amino acid stimulusGO:04320010.8CCL2, CTGF, SST
9response to drugGO:04249310.8TGFB2, SST, GAD1, CCL2, TIMP2
10heart morphogenesisGO:00300710.7VEGFA, EPHB4, TGFB2
11blood circulationGO:00801510.7ADM, CXCL12, CXCL10
12cell surface receptor signaling pathwayGO:00716610.7CXCL10, MIF, SST, CCL2
13response to woundingGO:00961110.7CTGF, ADM, TGFB2
14positive regulation of cell proliferationGO:00828410.7TGFB2, ADM, CXCL10, VEGFA, CTGF
15cell adhesionGO:00715510.6CCL2, EPHB4, CXCL12, VCAM1, VTN
16response to glucocorticoid stimulusGO:05138410.6ADM, PTGDS, CCL2
17positive regulation of angiogenesisGO:04576610.5ADM, ANGPT2, VEGFA
18cell-cell signalingGO:00726710.5SST, CXCL10, ADM, TGFB2
19platelet degranulationGO:00257610.4HGF, VEGFA, TGFB2
20signal transductionGO:00716510.2CCL2, ANGPT2, IGFBP1, CXCL10, CXCL12, ADM

Molecular functions related to Proliferative Diabetic Retinopathy according to GeneCards/GeneDecks:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1receptor bindingGO:00510210.7TGFB2, ADM, CXCL12, CXCL10, MIF, ANGPT2
2growth factor activityGO:00808310.6HGF, CTGF, VEGFA, CXCL12, TGFB2
3integrin bindingGO:00517810.6TIMP2, CTGF, VCAM1, VTN
4chemoattractant activityGO:04205610.5MIF, VEGFA, HGF
5metalloendopeptidase inhibitor activityGO:00819110.5TIMP3, TIMP2
6heparin bindingGO:00820110.4CCL2, CTGF, VEGFA, VTN
7chemokine activityGO:00800910.2CXCL12, CXCL10, CCL2

Products for genes affiliated with Proliferative Diabetic Retinopathy

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Proliferative Diabetic Retinopathy

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet